Skip to main content
Caplight Logo









Epoqe Pharma

Epoqe Pharma

Private
CopenhagenHealthcare & Life Scienceshttps://epoqepharma.com/

Last Round

Seed

Jan 28, 2025

Total Funding Raised

$13.93M

Company Overview

Epoqe Pharma is a biopharmaceutical company that develops novel peptide-based treatments for cardiovascular diseases, with a primary focus on Acute Myocardial Infarct (AMI).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

peptide therapeuticsacute myocardial infarctionAMIfirst-in-class drugcardiovascular diseaseheart attack therapyCGRPpreclinical pharmadrug discoveryinfarct size reductioncalcitonin gene-related peptidebiopharmaceuticaldrug licensingmyocardial perfusion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epoqe Pharma Comparables

Compare Epoqe Pharma with similar companies based on industry and business-model similarity.

Epoqe Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ResoTher Pharma
76%
Zealand Pharma
70%
Recardio
69%

Epoqe Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 28, 2025
Series AJan 1, 2025
GrantJul 7, 2023

Key People

Founding team and executive leadership

Anette Sams

Chief Executive Officer and co-founder

Founding Team

Epoqe Pharma Investors

Notable investors and investment history

Epoqe Pharma investors
InvestorRounds
Lundbeck FoundationGrant
Innovation Fund DenmarkGrant
Lundbeckfonden BioCapitalSeries A, Seed
Sofinnova PartnersSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Grew 400% QoQ from 1 to 5 employees.

  • Nov 8, 2025

    Monthly visitors grew 104% MoM, reaching 784.

Epoqe Pharma Filings

Explore SEC and related filing metadata, where available.

Epoqe Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Epoqe Pharma's valuation, stock price, and market status.

Is Epoqe Pharma a public or private company?

Epoqe Pharma is a private company.

What is the current stock price of Epoqe Pharma?

Epoqe Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is Epoqe Pharma worth (valuation)?

Valuation information for Epoqe Pharma is not publicly available.

Can I buy Epoqe Pharma stock?

Epoqe Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Epoqe Pharma's last funding round?

Funding round information for Epoqe Pharma is not publicly available.

Who are the main investors in Epoqe Pharma?

Investor information for Epoqe Pharma is not publicly disclosed.

Will Epoqe Pharma IPO soon?

No public IPO plans have been announced for Epoqe Pharma.

How can I track Epoqe Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epoqe Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range5
Year Founded2021
Last FundingJan 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?